An Open-Label Study to Evaluate Retreatment With LIPO-202
Status: | Active, not recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | March 2015 |
Evaluate the safety of three 8-week courses of treatment with LIPO-202 in non-obese patients
who have central abdominal bulging. Efficacy measurements will also be collected.
who have central abdominal bulging. Efficacy measurements will also be collected.
Inclusion Criteria:
- Provided consent
- Healthy male or non-pregnant female subjects
- BMI < 30 kg/m2
- Stable diet and exercise routine
- Central abdominal bulging that is at least "Slight Bulge, Not Flat"
Exclusion Criteria:
- Have had any treatment of the fat around your abdomen, including surgical procedures
(tummy tuck, liposuction), injections for fat loss or treatments with devices to
reduce fat in your abdomen
- Plan on starting a weight loss or exercise program during the study.
- Be a woman who is pregnant, breast feeding, have had a baby within 6 months and/or
not using appropriate birth control.
- Known hypersensitivity to study drugs
- Prior or current enrollment in any Neothetics (formerly Lithera) study involving
LIPO-102 or LIPO-202
We found this trial at
8
sites
Click here to add this to my saved trials
7810 Louis Pasteur
San Antonio, Texas 78229
San Antonio, Texas 78229
210-692-1382
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials